Aberrant alternative exon use and increased copy number of human metalloprotease-disintegrin ADAM15 gene in breast cancer cells

Genes Chromosomes and Cancer

Volumn 41, Issue 4, 2004, Pages 366-378

  Ortiz, Rebekka M ^a   Kärkkäinen, Iivari ^a   Huovila, Ari Pekka J ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DISINTEGRIN; METALLOPROTEINASE;

ADAM15 GENE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN CELL; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAM PROTEINS; ALTERNATIVE SPLICING; BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; DISINTEGRINS; EXONS; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; RNA, MESSENGER;

EID: 8444253005     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20102     Document Type: Article

References (52)

1. Abram CL, Seals DF, Pass I, Salinsky D, Maurer L, Roth TM, Courtneidge SA. 2003. The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem 278:16844-16851.
2. Arndt M, Lendeckel U, Rocken C, Nepple K, Wolke C, Spiess A, Huth C, Ansorge S, Klein HU, Goette A. 2002. Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria. Circulation 105:720-725.
3. Becherer JD, Blobel CP. 2003. Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs). Curr Top Dev Biol 54:101-123.
4. Blobel CP. 2002. Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding. Inflamm Res 51:83-84.
5. Böhm BB, Aigner T, Gehrsitz A, Blobel CP, Kalden JR, Burkhardt H. 1999. Up-regulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage. Arthritis Rheum 42:1946-1950.
6. Böhm BB, Aigner T, Blobel CP, Kalden JR, Burkhardt H. 2001. Highly enhanced expression of the disintegrin metalloproteinase MDC15 (metargidin) in rheumatoid synovial tissue. Arthritis Rheum 44:2046-2054.
7. Bosse F, Petzold G, Greiner-Petter R, Pippirs U, Gillen C, Muller HW. 2000. Cellular localization of the disintegrin CRII-7/rMDC15 mRNA in rat PNS and CNS and regulated expression in postnatal development and after nerve injury. Glia 32:313-327.
8. Cao V, Kang Q, Zolkiewska A. 2001. Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1. Biochem J 357:353-361.
9. Cooke HJ, Hindley J. 1979. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acids Res 6:3177-3197.
10. Cousin H, Gaultier A, Bleux C, Darribere T, Alfandari D. 2000. PACSIN2 is a regulator of the metalloprotease/disintegrin ADAM13. Dev Biol 227:197-210.
11. Emi M, Katagiri T, Harada V, Saito H, Inazawa J, Ito I, Kasumi F, Nakamura Y. 1993. A novel metalloprotease/disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers. Nat Genet 5:151-157.
12. Fogel M, Gutwein P, Mechtersheimer S, Riedle S, Stoeck A, Smirnov A, Edler L, Ben-Arie A, Huszar M, Altevogt P. 2003. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362:869-875.
13. Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Florenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, Muller C, Sanvito F, Kononen J, Nesland JM, Fodstad O, Reymond A, Kallioniemi OP, Arrigoni G, Ballabio A, Myklebost O, Zollo M. 2001. Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity. Oncogene 20:6881-6890.
14. Galliano MF, Huet C, Frygelius J, Polgren A, Wewer UM, Engvall E. 2000. Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha-actinin-2, is required for myoblast fusion. J Biol Chem 275:13933-13939.
15. Gee JM, Knowlden JM. 2003. ADAM metalloproteases and EGFR signalling. Breast Cancer Res 5:223-224.
16. Gendler SJ, Cohen EP, Craston A, Duhig T, Johnstone G, Barnes D. 1990. The locus of the polymorphic epithelial mucin (PEM) tumour antigen on chromosome 1q21 shows a high frequency of alteration in primary human breast tumours. Int J Cancer 45:431-435.
17. Gschwind A, Hart S, Fischer OM, Ullrich A. 2003. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. Embo J 22:2411-2421.
18. Gutwein P, Oleszewski M, Mechtersheimer S, Agmon-Levin N, Krauss K, Altevogt P. 2000. Role of Src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J Biol Chem 275:15490-15497.
19. Harada T, Nishie A, Torigoe K, Ikezaki K, Shono T, Maehara Y, Kuwano M, Wada M. 2000. The specific expression of three novel splice variant forms of human metalloprotease-like disintegrin-like cysteine-rich protein 2 gene inBrain tissues and gliomas. Jpn J Cancer Res 91:1001-1006.
20. Herren B, Raines EW, Ross R. 1997. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. Faseb J 11:173-180.
21. Herren B, Garton KJ, Coats S, Bowen-Pope DF, Ross R, Raines EW. 2001. ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions. Exp Cell Res 271:152-160.
22. Horiuchi K, Weskamp G, Lum L, Hammes HP, Cai H, Brodie TA, Ludwig T, Chiusaroli R, Baron R, Preissner KT, Manova K, Blobel CP. 2003. Potential role for ADAM15 in pathological neovascularization in mice. Mol Cell Biol 23:5614-5624.
23. Howard L, Nelson KK, Maciewicz RA, Blobel CP. 1999. Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1. J Biol Chem 274:31693-31699.
24. Huang L, Eeng L, Yang L, Zhou W, Zhao S, Li C. 2002. Screen and identification of proteins interacting with ADAM19 cytoplasmic tail. Mol Biol Rep 29:317-323.
25. Iba K, Albrechtsen R, Gilpin BJ, Loechel F, Wewer UM. 1999. Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol 154:1489-1501.
26. Iba K, Albrechtsen R, Gilpin B, Frohlich C, Loechel F, Zolkiewska A, Ishiguro K, Kojima T, Liu W, Langford JK, Sanderson RD, Brakebuseh C, Fassler R, Wewer UM. 2000. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol 149:1143-1156.
27. Kang Q, Cao Y, Zolkiewska A. 2000. Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells. Biochem J 352:883-892.
28. Kang Q, Cao Y, Zolkiewska A. 2001. Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells. J Biol Chem 276:24466-24472.
29. Kärkkäinen I, Karhu R, Huovila AP. 2000. Assignment of the ADAM15 gene to human chromosome band 1q21.3 by in situ hybridization. Cytogenet Cell Genet 88:206-207.
30. Krätzschmar J, Lum L, Blobel CP. 1996. Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence. J Biol Chem 271:4593-4596.
31. Kriventseva EV, Koeh I, Apweiler R, Vingron M, Bork P, Gelfand MS, Sunyaev S. 2003. Increase of functional diversity by alternative splicing. Trends Genet 19:124-128.
32. Le Pabic H, Bonnier D, Wewer UM, Coutand A, Musso O, Baffet G, Clement B, Theret N. 2003. ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 37:1056-1066.
33. Martin J, Eynstone LV, Davies M, Williams JD, Steadman R. 2002. The role of ADAM 15 in glomerular mesangial cell migration. J Biol Chem 277:33683-33689.
34. McCulloch DR, Harvey M, Herington AC. 2000. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol Cell Endocrinol 167:11-21.
35. Mori S, Tanaka M, Nanba D, Nishiwaki E, Ishiguro H, Higashiyama S, Matsuura N. 2003. PACSIN3 binds ADAM12/meltrin alpha and upregulates ectodomain shedding of heparin-binding EGF-like growth factor. J Biol Chem 278:46029-46034.
36. Nelson KK, Schlondorff J, Blobel CP. 1999. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor alpha convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2beta. Biochem J 343:673-680.
37. Orban TI, Olah E. 2003. Emerging roles of BRCA1 alternative splicing. Mol Pathol 56:191-197.
38. O'Shea C, McKie N, Buggy Y, Duggan C, Hill AD, McDermott E, O'Higgins N, Duffy MJ. 2003. Expression of ADAM-9 mRNA and protein in human breast cancer. Int J Cancer 105:754-761.
39. Peiretti F, Deprez-Beauclair P, Bonardo B, Aubert H, Juhan-Vague I, Nalbone G. 2003. Identification of SAP97 as an intracellular binding partner of TACE. J Cell Sci 116:1949-1957.
40. Poghosyan Z, Robbins SM, Houslay MD, Webster A, Murphy G, Edwards DR. 2002. Phosphorylation-dependent interactions between ADAM 15 cytoplasmic domain and Src family protein-tyrosine kinases. J Biol Chem 277:4999-5007.
41. Shimizu E, Yasui A, Matsuura K, Hijiya N, Higuchi Y, Yamamoto S. 2003. Structure and expression of the murine ADAM 15 gene and its splicing variants, and difference of interaction between their cytoplasmic domains and Src family proteins. Biochem Biophys Res Commun 309:779-785.
42. Stickeler E, Kittrell F, Medina D, Berget SM. 1999. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18:3574-3582.
43. Suzuki A, Kadota N, Hara T, Nakagami Y, Izumi T, Takenawa T, Sabe H, Endo T. 2000. Meltrin alpha cytoplasmic domain interacts with SH3 domains of Src and Grb2 and is phosphorylated by v-Src. Oncogene 19:5842-5850.
44. Tanner MM, Tirkkonen M, Kallioniemi A, Isola J, Kuukasjarvi T, Collins C, Kowbel D, Guan XY, Trent J, Gray JW, Meltzer P, Kallioniemi OP. 1996. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res 56:3441-3445.
45. Tian BL, Wen JM, Zhang M, Xie D, Xu RB, Luo CJ. 2002. The expression of ADAM12 (meltrin alpha) in human giant cell tumours of bone. Mol Pathol 55:394-397.
46. Waltz MR, Pandelidis SM, Pratt W, Barnes D, Swallow DM, Gendler SJ, Cohen EP. 1998. A microsatellite within the MUC1 locus at 1q21 is altered in the neoplastic cells of breast cancer patients. Cancer Genet Cytogenet 100:63-67.
47. Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH, Lee MP. 2003. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res 63:655-657.
48. Weskamp G, Kratzschmar J, Reid MS, Blobel CP. 1996. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J Cell Biol 132:717-726.
49. White JM. 2003. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 15:598-606.
50. Wu E, Croucher PI, McKie N. 1997. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochem Biophys Res Commun 235:437-442.
51. Yoshimura T, Tomita T, Dixon MF, Axon AT, Robinson PA, Crabtree JE. 2002. ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. J Infect Dis 185:332-340.
52. Zhu P, Sun Y, Xu R, Sang Y, Zhao J, Liu G, Cai L, Li C, Zhao S. 2003. The interaction between ADAM 22 and 14-3-3zeta: regulation of cell adhesion and spreading. Biochem Biophys Res Commun 301:991-999.